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Introduction. Chronic Obstructive Pulmonary Disease (COPD) people suffer from severe physical impairments, which often
elicit significant psychological distress and impact their quality of life. This meta-analysis aimed to assess evidence from the
scientific literature on the effects of relaxation techniques. Methods. We investigated 9 databases to select 25 RCTs. Studies included
both inpatients and outpatients with COPD. Both respiratory and psychological outcomes were considered. Results. Relaxation
techniques showed a little positive effect on the value of the percentage of predicted FEV1 (𝑑 = 0.20; 95% Cl: 0.40–−0.01) as well as
a slight effect on levels of both the anxiety (𝑑 = 0.26; 95% Cl: 0.42–0.10) and depression (𝑑 = 0.33; 95% Cl: 0.53–0.13). The higher
effect size was found in the quality of life value (𝑑 = 0.38; 95% Cl: 0.51–0.24). The assessed quality of the studies, based on the PEDro
Scale, was generally medium/high. Conclusion. Relaxation training can have a moderate impact on both psychological well-being
and respiratory function, resulting in noticeable improvements in both. Although higher quality research is required, our results
sustain the importance of relaxation techniques as a tool to manage COPD.

1. Introduction
The Global Initiative for Chronic Obstructive Lung Disease
(GOLD) defined Chronic Obstructive Pulmonary Disease
(COPD) as airflow limitation that tends to not be fully
reversible and which is usually both progressive and associated with an abnormal inflammatory response of the lungs to
noxious particles or gases [1]. It is predicted that the burden
of COPD will be even more apparent in the coming decades,
due to the continuous exposure to risk factors as well as the
increase in life-expectancy [2, 3]. It is expected that COPD
will move from the sixth to the fourth cause of mortality and
morbidity in the world [4]. Moreover, this illness accounts for
significant health-care costs worldwide [5], prevailing both
in developed and in developing countries [2]. It is important
to note that COPD severity is related to a worse healthrelated quality of life [6], which is also characterized by a
worsening in emotional well-being, shown to be related to

fatigue and other coping strategies of everyday life [7]. The
psychological distress of these patients is often characterized
by both anxiety and depression [8] as well as by reported
feelings of helplessness, powerlessness, loss of mobility and
freedom, tense relationships, panic attacks, and growing
social isolation in patients’ narrations [9–11]. Furthermore,
the cognitive profiles of these patients are compromised by
hypoxemia, hypercapnia [12], and sleep problems, caused
by coughing and breathlessness [13, 14]. State-of the-art
research methods allow us to highlight how, despite the
fact that patients with COPD often exhibit symptoms of
psychological distress, interventions dedicated to them tend
to pay attention mostly to the physical aspects of the disease,
with a considerable waste of resources [15]. However, it could
be important to consider also the psychological aspects,
because they can have significant impacts on both the quality
of life of individuals and on the therapeutic relationship.
This also might be a way to check if the active management
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of the disease also from a psychological point of view can
improve outcomes and reduce the waste of material and social
resources [16]. In this perspective, relaxation techniques
are often used to inhibit anxiety, increasing the patient’s
perception of self-control or modulating his or her emotions,
and in order to promote the perceived well-being of the
subject. However, the effectiveness of these techniques to
reduce COPD patients’ symptoms is not always clear, since
studies are characterized by different methodological quality
rendering the results often inconsistent. Indeed, many studies
showed improvements in oxygen saturation during the use of
a relaxation method, such as guided imagery, even in patients
with COPD [17, 18]. Moreover, even if some researchers discovered that methods such as progressive muscle relaxation
can reduce psychological distress in patients with COPD
[19–21], the cost-effectiveness of adding these techniques to
a rehabilitation program is not always clear [21, 22]. It is
also important to note that drug treatments are not always
effective in providing a certain level of relief in case of
dyspnea, especially in cases where the causes of the disorder
are unclear [23]. Due to this fact, some authors have evaluated
the safety, feasibility, and effectiveness in reducing dyspnea
and anxiety of programs based on relaxation trainings, such
as yoga. Results revealed that these programs were indeed
effective and also resulted in better functioning in daily life.
Moreover, they detect a distress decrease and then a better
functioning in daily life [24]. Likewise, other studies stressed
the effectiveness of yoga in relieving levels of anxiety and
depression, increasing sense of control and self-esteem, and
instilling hope in patients [25–27]. Other techniques, such
as Tai Chi [28, 29], biofeedback, and breathing control, were
used, resulting in an improvement in breathing capacity
and function of the extremities and increasing the strength
of muscles important for respiration [30–32]. Finally, other
previous studies stressed the importance of the application of
methods such as distraction therapy [33–35] or acupressure
[36], since they have been proven to improve psychological
well-being and physiological parameters.
It is important to note that there is a lack of literature providing evidence about the efficacy of relaxation techniques in
COPD patients both in terms of practicability and feasibility
in everyday life and in terms of health improvements. There
are not clear data about immediate and long term effects of
these techniques.
Given this lack of knowledge, we focused our meta-analysis on the effectiveness of relaxation techniques on COPD
patients. Our goal is to summarize and evaluate existing evidence of studies concerning the effects of such interventions
so that health professionals can adopt and integrate them
to improve the quality of life of their COPD patients. In
particular, we derived some following hypotheses from the
literature.
(i) Relaxation techniques can be effective in training
patients with COPD, but only under certain conditions.
(ii) There is a relationship between the use of relaxation
techniques and the reduction of anxiety and depression, as well as the improvement of quality of life and

the percentage of Forced Expiratory Volume in the
First Second (FEV1 ).

2. Method
2.1. Literature Search Strategy. The main aim of the study
selection is to examine the levels of anxiety, depression,
quality of life (QoL), and percentage of predicted FEV1 of
inherent value both before and after treatment.
We have referred to the following research computer
databases: PsycINFO, PubMed, Scopus, Web of Science,
MEDLINE, Cochrane, PsycARTICLES, SpringerLink, and
ClinicalTrials.gov. Unpublished studies were not considered.
The search strategy used a combination of the following
words, searched as title, key words, abstract, and MeSH
subjects heading terms: “relaxation,” “relaxation training,”
“relaxation technique,” “relaxation therapy,” “progressive
muscle relaxation,” “progressive relaxation,” “meditation,”
“guided imagery,” “distraction therapy,” and “biofeedback”,
each of them together with the term “copd” by the Boolean
operator “AND.” Moreover, references cited in the research
studies were gathered and recent reviews were scanned for
further trials, using “cited by” search tool. In addition,
authors who discussed this topic in the past were contacted
in order to gather more data and information about their
studies. We have selected only articles published in English
between 1970 and 2015 and studies performed only on human
adults.
2.2. Inclusion and Exclusion Criteria. Before implementing
the literature review, we defined the inclusion and exclusion
criteria (Table 1). We included only Randomized Controlled
Trials both prospective and single or double blinds. Studies
needed to include subjects both hospitalized and outpatients,
who were affected by COPD at varying levels of severity
and who had very severe airflow obstruction. Studies that
included subjects who did not have this diagnosis were not
accepted even if they were in the control group to insure that
both groups were comprised of subjects similar in sociodemographic and clinic characteristics in both groups. We have
also excluded studies in which the treatment provided for
comparison between a control group and one subjected to
a pulmonary rehabilitation was a relaxation component that
constituted only a few minutes, or studies that compare two
rehabilitation programs in which the relaxation is present
in equivalent terms. We have also required that the control
group employ a usual rehabilitation treatment or a placebo,
which must consist of activities that are not truly relaxing (i.e.,
home crafts). As we have already stated, however, studies had
to detect at least one of the variables considered moderators
of the effect, that is, anxiety, depression, quality of life, or
percentage of predicted FEV1 of inherent value. Furthermore,
in order to make the effect size computation possible, only
studies that reported sufficient communication of the results
were included (e.g., mean and standard deviation). Moreover,
studies had to investigate the effects of one or more relaxation
trainings, such as relaxation techniques, progressive muscle
relaxation, guided imagery, distraction therapy, biofeedback,
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Table 1: Inclusion and exclusion criteria.
Category

Criteria

Study population

Individuals hospitalized or outpatients
Patients with Chronic Obstructive Pulmonary Disease (COPD) or with severe airflow obstruction

Time period

1970–2014

Publication languages

English

Admissible study designs

Interventions

Control group

Variables
Other information

Randomized Controlled Trial (RCT)
Studies that provide sufficient detail regarding methods and results to enable use and adjustment of the
data to effect size computation
Must approach one or more of the following interventions: (i) relaxation techniques; (ii) progressive
muscle relaxation; (iii) guided imagery; (iv) distraction therapy; (v) biofeedback; (vi) breathing techniques
(diaphragmatic breathing, Pursed-Lips Breathing); (vii) yoga; (viii) Tai Chi; (ix) acupressure
Not allowed studies providing for the comparison between a control group and one subjected to a
pulmonary rehabilitation in which the relaxation constituted only one component of a few minutes
Not allowed studies that compared two rehabilitation programs in which relaxation was present equally
Patients with Chronic Obstructive Pulmonary Disease (COPD), hospitalized or outpatients
Not allowed studies with healthy subjects and volunteers or with other diseases in the control group
It has not been subjected to any treatment or to usual rehabilitation treatments or placebo or to activities
not expressly relaxing (i.e., handcrafts)
Must assess baseline and outcome data for one or more of the following variables: (i) percentage of Forced
Expiratory Volume in One Second (FEV1 ); (ii) anxiety; (iii) depression; (iv) quality of life (QoL)
If possible, they should provide data on other important variables, comprising those in text and tables: (i)
number of subjects; (ii) mean age; (iii) geographic origin; (iv) assessment measures; (v) homework; (vi)
number of session or protocol length; (vii) trial context.

breathing techniques (diaphragmatic breathing and PursedLips Breathing), yoga, or Tai Chi.
2.3. Study Selection. We identified the potential articles
and read the abstracts to determine whether they met the
inclusion criteria. We excluded 77 studies, because they were
case reports, letters, reviews, editorials, or cohort studies (see
Figure 1). For the remaining papers, we read the full text:
in this way, an additional 15 studies that did not include an
appropriate comparison group were excluded (see Figure 1).
Though consistent with our inclusion and exclusion criteria,
another 13 studies were excluded, because they adopted a
different intervention such as Inspiratory Muscle Training
(IMT), autogenic drainage, psychoeducational care, or active
cycle breathing techniques (ACBT). After the exclusion of
these 28 studies, an additional 3 studies were excluded
because they were not in English, 6 were excluded because
they were not obtainable, and 19 were excluded because they
did not meet one of the inclusion criteria shown above. The
resulting meta-analysis included 25 studies (see Figure 1).
Only one of the studies included is under submission [55]
while 24 are published in a scientific journal.
2.4. Data Extraction and Coding. According to the above
criteria, we extracted data related to the variables considered
potential predictors of study results, which included anxiety,
depression, quality of life, or percentage of predicted FEV1 of
inherent value, examined before and after relaxation training.
It is important to note that, in this meta-analysis, the coding
system of studies was configured as directed and was based on

a careful reading of the articles. We have also codified data
on study design, year, geographic origin of the study, number
of subjects and number of males and females, number of
subjects per group, patients diagnosis, mean age, intervention
characteristics (type of relaxation training, duration, number
of sessions, concurrent therapies, trial context, and homework), and assessment measures. Basic descriptive information about the statistical procedures used in the research was
also annotated. Finally, where possible, the number of cases of
failures and/or retirements and discontinuities to treatment
was reported.
2.5. Risk of Biases Assessment. Two authors evaluated the risk
of biases independently. For this purpose, the Assessment
Tool by Cochrane Collaboration was used. It consists of
seven items regarding the selection, performance, detection,
attrition, reporting, and other sources of bias [56]. The two
authors mentioned previously discussed the incongruities
with the corresponding author (Figures 2 and 3). We used
funnel plots to check for the existence of publication bias
(Figures 5, 7, 9, and 11). Finally, we performed forest plots
(Figures 6, 8, 10, and 12) by using Review Manager Software
5.3 (Cochrane Collaboration).
2.6. Methodological Quality. We have also assessed the
methodological quality of the RCTs included in the metaanalysis (Table 2). For this purpose, as appropriate by studies
design, we used the PEDro Scale, which is based on the
Delphi List, developed by Verhagen et al. to evaluate the RCTs
quality [57]. Two researchers evaluated the quality of each
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Studies identified
and screened
Excluded:
1300
Full text assessed:
158

Screening

77 were excluded because of
inadequate study design
15 did not include appropriate
comparison group

Eligibility

66 assessed for
eligibility
13 did not address
intervention of interest
19 did not meet other
inclusion criteria
3 were not in English

Included

6 were not obtainable

25 studies were included

Figure 1: Flow chart of study selection.
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Figure 2: Risk of bias graph: judgments about each risk of bias item presented as percentages across all included studies.
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Figure 3: Risk of bias summary: review authors’ judgements about each risk of bias item for each included study.

study, independently. Each paper received a one point on each
satisfied item (except the first item) out of the total score of the
PEDro Scale (range of 0–10). Also in this specific case, they
discussed the discrepancies with the corresponding author.
2.7. Data Analysis. Data analysis was performed using the
statistical software Statistical Package for Social Science
(SPSS), Version 20. All data extracted were reported as they
were given in the publication.

The effect sizes or size effects were calculated for each
study, in relation to the variables considered. They were calculated between both groups at “Time 2,” commensurate to
an average of 8–12 weeks. These values were computed using
Cohen’s 𝑑, which allows the determination of the overlap
between the distributions of the experimental group and the
control group. When the necessary data were available to
estimate the standardized difference between the means of
the groups (e.g., mean and standard deviation), we applied
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Classes for
Chronic
Obstructive
Pulmonary
Disease: A
Randomized
Controlled
Trial
Role of
Pranayama in
Rehabilitation
of COPD
Patients: A
Randomized
Controlled
Study
Adjunct
Treatment
with Yoga in
Chronic
Severe
Airways
Obstruction
Pulmonary
Rehabilitation
Improves
Depression,
Anxiety,
Dyspnea, and
Health Status
in Patients
with COPD

[48]

[47]

2006

2012

Year

USA

2007

Australia 1978

India

[25]

References

UK

Country

[46]

Yoga

Relaxation,
breathing
techniques,
conservation
of energy

Student’s
𝑡-test

𝑡-test for
independent
and
dependent
samples;
Pearson’s
correlation
test

RCT

RCT

Yoga

Student
NewmanKeuls
tests

Prospective
RCT

Study design

ANCOVA

Statistical analysis

RCT

Type of training
Breathing
techniques,
relaxation
training,
vocalization

Type of subjects

Usual care

COPD
patients

STAI;
GOLD
SGRQ;
3
BDI

Only
FEV1

Patients with
severe airways
obstruction, GOLD
Physiotherapy
with or
3
without
emphysema

GOLD HADS;
3
SF-36

SGRQ

COPD
patients

COPD
patients

Instrument

GOLD
2-3

Usual physical
activity

Film
workshops

Control group activity

Table 2: Continued.
Pulmonary functioning

Characteristics of the studies
Individual/group
Group

Group

Group

Group

Homework
Duration
16 sessions

𝑁∧ of sessions

𝑁∧ subjects

0

No

8
weeks

24 sessions

24 10 14

0

0

13 11

𝑁∧ experimental subjects

3 times a week
for the first
9
four weeks, 2
Nd
24 12 12
months for the other
four, and 1 for
the remaining

33

𝑁∧ third group
0

3
Half an hour,
months
everyday

8
weeks

𝑁∧ control subjects

48 23 22

No

Yes

Dropout
0

0

3

8

Mean age
𝑁∧ male

𝑁∧ female

38

6

18

Nd Nd

7

64.5

60

52.2

Nd Nd 68.4

Quality
5

4

5

6
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SD age

USA

[52]

Australia

USA

[50]

Short-Form
Sun-Style Tai
Chi as an
Exercise
Training
Modality in
People with
COPD

China

Country

[51]

[49]

Title

Relaxation to
Reduce
Dyspnea and
Anxiety in
COPD
Patients
One-Session
Cognitive
Behavioural
Therapy for
Elderly
Patients with
Chronic
Obstructive
Pulmonary
Disease

References

Effectiveness
of
Incorporating
Tai Chi in
Pulmonary
Rehabilitation
Program for
Patients in
Primary
Health Care
(COPD)

Study design

Year

2001

1992

2010–
2012

Sit quietly

2 h of COPD
education,
followed by
weekly calls

Relaxation
training and
breathing
techniques

𝑡-test,
chi-square,
MANOVA

RCT, single
blind

Usual medical
care

Progressive
muscle
relaxation

Paired
𝑡-tests and
repeated
measures
analysis of
variance
with
intentionto-treat
analysis

Pulmonary
rehabilitation
without
Tai-Chi

ANOVA

Sun-Style Tai
Chi and
breathing
exercises

ANCOVA

Statistical analysis

Tai Chi and
relaxation
exercises

Type of training

RCT

RCT

Prospective
2011–
RCT, single
2013
blind

Control group activity

Table 2: Continued.

Type of subjects
COPD
patients

COPD
patients

COPD
patients

COPD
patients
SGRQ

Instrument

Nd

GOLD
2

GDS;
BAI;
SF-36

STAI

GOLD CRQ;
2
HADS

GOLD
2

Pulmonary functioning

Characteristics of the studies
Individual/group

Homework
Yes

Group

Yes

Individual Yes

Group

Group

Duration
6
weeks

Nd

3
months

6
No
months

𝑁∧ of sessions

𝑁∧ control subjects
𝑁∧ third group

𝑁∧ experimental subjects
21 27

26 13 13

42 19 19

0

0

0

192 94 98 0

𝑁∧ subjects

1 session,
followed by
53
daily sessions
autonomously

3-4 times a
week

12 sessions

Nd

Dropout
5

8

4

28
(followup) 26
(disc)

𝑁∧ male

𝑁∧ female

27

9

44

Nd Nd

15

17 175

Mean age
71.3

67

73

74

Quality
SD age
5.9

8

4

4

6

6.624 5
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[53]

Title

Comparison
of the
Effectiveness
of Music and
Progressive
Muscle
[54]
Relaxation for
Anxiety in
COPD: A
Randomized
Controlled
Pilot Study
Relax and
Breathe
Deeply: A
Quick
Relaxation
[55],
Training for
[submitted]
People with
Chronic
Obstructive
Pulmonary
Disease

References

Effects of
Psychotherapy
in Moderately
Severe COPD:
A Pilot Study

Country

2009

2015

Italy

1997

Year

India

UK

Study design

ANOVA

Betweengroups
comparisons:
MannRCT, single
Whitney 𝑈
blind
test; within
groups comparisons:
Wilcoxon
test

RCT

RCT

Paired
𝑡-tests,
unpaired
tests

Statistical analysis

They attended
the laboratory
for seven
times, usual
visits

Type of training
Muscle
relaxation,
breathing
technique,
distraction
therapy

Relaxation
training and
breathing
techniques
They watched
a
documentary
movie

Music

Control group activity

Progressive
muscle
relaxation
(PMR)

Table 2: Continued.

Type of subjects
COPD
patients

COPD
patients

COPD
patients

Instrument
STAI

Individual/group
Yes

Individual Nd

Group

Homework

VAS;
STAI;
GOLD
PANAS; Individual No
2-3
Short
FSS

Nd

GOLD HADS;
2-3-4 SGRQ

Pulmonary functioning

Characteristics of the studies

Duration
1 day

1 day

6
weeks

𝑁∧ of sessions
1 session

2 sessions

6 sessions

𝑁∧ subjects

𝑁∧ experimental subjects
10

8

𝑁∧ control subjects

38 19 19

72 32 32

18

𝑁∧ third group
0

0

0

Dropout
0

8

0

𝑁∧ female

8

𝑁∧ male
15

Mean age
63

72.2

7.5

SD age
23 72.66 8.68

19 45

10

Quality
7

6

3
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them to the following formula: 𝑑 = (𝑀1 − 𝑀2)/𝑆 [58].
𝑀1 is the mean of the experimental group, 𝑀2 is the mean
of the control group, and 𝑆 is the standard deviation of the
general sample, which is computed with the formula: 𝑆 =
√((𝑛1 − 1)𝑠12 + (𝑛2 − 1)𝑠22 )/(𝑛1 + 𝑛2 − 2). When the necessary
data was not available to calculate effect sizes using this
formula, we proceeded using other expressions and then
converted them into 𝑑 through appropriate equations [59,
60]. These effect sizes were interpretable in terms of Cohen’s
convention, whereby 0.2 is small, 0.5 is medium, and 0.8 is
large [61]. Moreover, for each study, we calculated the effect
size introducing a correction term capable of producing an
undistorted standardized difference between means, based
on Hedges’ formula [62]. Furthermore, because the effect
is indicative of the intensity of the relationship between
independent and dependent variables, the effect’s convertibility measured as the difference between averages becomes
relevant, also in terms of correlation: 𝑟 = 𝑑/√(4 + 𝑑2 ) [60].
After calculating the effect sizes for each study included, we
calculated the index medium that expresses the extent of the
overall effect. Later, we calculated the limits of the confidence
interval around the mean value found, as well as the average
of the effects from 𝑟, using the appropriate formulas [60]. We
also tested the invariance between studies considered in the
meta-analysis, designed to examine whether the effects share
a common effect size or if the variability requires clarification
from the input variables from which the effects are taken
[63]. In order to assess the relationship between predictors
and most effect sizes considered, we performed multiple
regressions, weighted by the reciprocal of the variance of the
same effects. However, we calculated the fail-safe number,
which is an index regarding the valuation of stability analysis
carried out and the Binomial Effect Size Display (BESD), able
to interpret the indices of effect size [64]. Heterogeneity was
evaluated via the chi-square test. Finally, it should be noted
that, where possible, significance levels, effects sizes, odds
ratio, and 95% Cls were calculated.

3. Results
3.1. Description of Studies. We reviewed 158 full text papers
and 25 of them met the inclusion criteria (see Figure 1). We
included only RCTs, 5 of which were prospective RCTs; 2
RCTs used a block randomization and 4 were single blind.
They involved only people with COPD, mainly moderate
to severe; one study considered COPD and asthma patients
with Flexible Bronchoscopy (FB) and another one included
patients with severe airflow obstruction, with or without
emphysema. As regards the publication’s year, four are dated
1978, 1992, 1995, and 1997, respectively, while the others
are all dated from 2000 to 2015. The countries in which
the studies were conducted can be broken down into the
following: the United States of America (44%), China (12%),
the United Kingdom (12%), Brazil (8%), Australia (8%),
India (8%), Germany (4%), and Italy (4%). The relaxation
methods included were the following: progressive muscle
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relaxation (PMR), breathing techniques (retrained or rhythmic breathing and Pursed-Lip Breathing (PLB), diaphragmatic breathing (DB)), distraction therapy, yoga, Tai Chi,
and biofeedback (Respiratory Biofeedback Training (RBF) or
Ventilation Biofeedback Training (VBT)). 12 of these studies
(48%) included a combination of these techniques (e.g.,
breathing techniques and relaxation, etc.) (Table 2). In 10
studies (44%), patients underwent private relaxation training,
while 14 studies (56%) involved training in small groups.
Moreover, in 10 cases (40%) patients were required to do
exercises at home that could further enhance the effectiveness
of the techniques implemented, while in 13 studies (52%) they
were not required to. In 2 cases (8.3%) it was not specified.
In 3 studies, there were three groups, the third of which
was subjected to another treatment or to the experimental
treatment combined with other activities.
In case of multiple treatments reported in the same paper,
each group was considered separately and compared with a
control group.
As we have already specified, the comparison condition
of the control studies consisted of a usual rehabilitation,
laying down, placebo treatments, or activities that were not
particularly restful (i.e., handcraft works).
All studies met the inclusion criteria and therefore
detected one or more of the variables considered the predictors of the effect (FEV1 , anxiety, depression, and quality
of life). The main assessment measures used in the studies
included one or more of the following: State-Trait Anxiety
Inventory (STAI/SSAI) (8 studies, 32%), Hospital Anxiety
and Depression Scale (HADS) (5 studies, 20%), Centre of
Epidemiologic Studies of Depression Scale (CES-D) (4 studies, 16%), Beck Depression Inventory (BDI) (1 study, 4%) and
Geriatric Depression Scale (GDS) (1 study, 4%), and Beck
Anxiety Inventory (BAI) (1 study, 4%), which assessed anxiety
and/or depression. Instead, Chronic Respiratory Questionnaire (CRQ) (6 studies, 24%), Saint George’s Respiratory
Questionnaire (SGRQ) (9 studies, 36%), Quality of WellBeing (QWB) (1 study, 4%), Visual Analog Scale of QoL (1
study, 4%), and MOS Short Form-36 Health Survey (SF-36)
(6 studies, 24%) were used to measure the quality of life
(Table 2). A pulmonary function test was generally adopted
to assess the percentage of predicted FEV1 of inherent value
and only one study exclusively measured this value (1 study,
4.16%).
The pooled sample consisted of 1426 subjects (mean =
57.31; SD = 48.461; range = 10–206), in which 615 (mean =
26.3; SD = 21.648; range = 5–94) were allocated for the
experimental group, 627 (mean = 24,88; SD = 20,352; range =
5–98) were assigned for the control group, and, finally, 102
(mean = 3.92; SD = 14.043; range = 0–69) were for a third
group. The mean age of the subjects was 67,12 (SD = 8,09).
Dropout rate ranged from 0 to 48 subjects (12%). The reasons for these dropouts were not always reported. However, in
these cases, it was indicated that the patient had either died,
experienced a worsening in his or her clinical condition, or
discontinued treatment due to a lack of motivation. Followup studies were done only in a few of these cases.
Finally, regarding the statistical analysis generally used,
the analyses run on the 25 included studies, in addition
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to detecting the frequency characteristics and descriptive
statistics, were the following: 𝑡-test for independent samples
or paired samples, one-way ANOVA (analysis of variance),
factorial ANOVA, ANCOVA (analysis of covariance), and
MANOVA (multivariate analysis of variance). Rarely, the
nonparametric Wilcoxon signed-rank test and the MannWhitney 𝑈 test were applied (Table 2).
3.2. Overall Effect Sizes. Table 3 shows the effect sizes for each
study, considering the principle effect’s moderators.
The average effect, calculated considering what the “Time
2” of treatments (corresponding to an average of 8–12 weeks)
is on all trials and all variables considered moderators of
the effect, is 0.31 (95% Cl: 0.39–0.23). According to Cohen’s
conventional criteria [61], this effect turns out to have little
significance and it is positive.
The effect size relating to the value of the percentage of
predicted FEV1 is 0.20 (95% Cl: 0.40–0.00), indicating a slight
positive effect.
The effect of the studies with respect to the moderator
variable “anxiety” had a value of 0.26 (95% Cl: 0.42–0.10),
thus showing a small positive effect size. The effect size of the
moderator variable “depression” at the end of the intervention
is 0.33 (95% Cl: 0.53–0.13), indicating another little positive
effect.
Finally, the effect size of the moderator variable “quality
of life” had a value of 0.38 (95% Cl: 0.51–0.24), at the “end
of treatments,” being also positive and small. The Binomial
Effect Size Display (BESD), pertaining to the overall average
effect, allows us to infer a moderator variables’ improvement
of 63% with regard to the experimental group and of 37% for
the control group (“Time 2”).
3.3. Effect Size by Relaxation Techniques Implementation
and Types. The kind of intervention seems to influence the
efficacy of the treatment (Figure 4). In particular, there are
significant differences in the FEV1 (𝐹(3) = 34.242; 𝑝 =
0.000 𝑝 < 0.05; 𝜂 = 0.530; Observed Potential = 1.000),
comparing cases in which the breathing techniques were used
and those in which a combination of relaxation techniques
was used (𝑝 = 0.000 (95% Cl.: −0.101–−0.179)). There are
also differences in the FEV1 comparing cases in which a
combination of many relaxation techniques was used and
those in which yoga was used (𝑝 = 0.000 (95% Cl.: 0.439–
1.527)) and also comparing cases in which yoga and breathing
techniques were used (𝑝 = 0.001 (95% Cl.: 0.299–1.385)).
Finally, there is a significant difference between a combination of many relaxation techniques and the adoption of
the combination of relaxation therapies and the breathing
techniques (𝑝 = 0.000 (95% Cl.: −0.808–−0.729)).
Similarly, there are significant differences in the anxiety
(𝐹(5) = 7.176; 𝑝 = 0.000 𝑝 < 0.05; 𝜂 = 0.199; Observed
Potential = 0.999), depending on the type of intervention
adopted. The main differences are between the combination
of relaxation therapies and breathing techniques and the
implementation of many relaxation techniques (𝑝 = 0.000
(95% Cl.: −0.640–−0.328)) and between this second option
and yoga (𝑝 = 0.003 (95% Cl.: 0.46–0.358)).
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Considering depression, there are differences (𝐹(5) =
6.022; 𝑝 = 0.000; 𝜂 = 0.241; Observed Potential = 0.993)
between the adoption of a combination of techniques and
progressive muscle relaxation (𝑝 = 0.000 (95% Cl.: 0.209–
0.546)) or Tai Chi (𝑝 = 0.001 (95% Cl.: 0.572–0.235)).
Finally, in regard to the quality of life, differences (𝐹(6) =
13.292; 𝑝 = 0.000; 𝜂 = 0.273; Observed Potential = 1.000)
are between a combination of techniques and biofeedback
(𝑝 = 0.000 (95% Cl.: 0.41–−0.26)) or breathing techniques
(𝑝 = 0.038 (95% Cl.: −0.96–−0.01)), Distractive Therapies
(𝑝 = 0.001 (95% Cl.: 0.02–−0.17)), and relaxation therapies
only (𝑝 = 0.035 (95% Cl.: −1.31–−0.03)). Other significant
differences are between the implementation of Distractive
Therapies and breathing techniques (𝑝 = 0.010 (95% Cl.:
0.11–1.05)), relaxation therapies (𝑝 = 0.013 (95% Cl.: −1.40–
−0.013)), Tai Chi (𝑝 = 0.030 (95% Cl.: −0.61–−0.17)), and yoga
(𝑝 = 0.043 (95% Cl.: 0.02–2.12)).
Doing or not doing the homework was a factor that predicted a significantly different effect between groups; indeed,
doing the homework improves anxiety (𝐹(2) = 12, 041; 𝑝 =
0, 000 𝑝 < 0, 05; 𝜂 = 0.141; Observed Potential = 0.995; 𝑀 =
0.463 SD = 0.446 (yes homework); 𝑀 = 0.190; SD = 0.348
(no homework)) and depression (𝐹(1) = 6.991; 𝑝 = 0.010 𝑝 <
0.05; 𝜂 = 0.066; Observed Potential = 0.745; 𝑀 = 0.432;
SD = 0.376 (yes homework); 𝑀 = 0.246 SD = 0.331 (no
homework)).
Varying the implementation of the relaxation technique
(individual versus group) shows a significantly different effect
on anxiety (𝐹(1) = 18.242; 𝑝 = 0.000 𝑝 < 0.05; 𝜂 = 0.110;
Observed Potential = 0.989; 𝑀 = 0.454; SD = (group); 𝑀 =
0.176 SD = 0.355 (individual)) and on depression (𝐹(1) =
29.125; 𝑝 = 0.000 𝑝 < 0.05; 𝜂 = 0.227; Observed Potential =
1.000; 𝑀 = 0.504 (group); SD = 0.423; 𝑀 = 0.158 SD = 0.159
(individual)). This aspect has a very slight yet significant effect
on the quality of life (𝐹(1) = 3.778; 𝑝 = 0.053 𝑝 < 0.05;
𝜂 = 0.017; Observed Potential = 0.490; 𝑀 = 0.478 SD = 0.474
(individual); 𝑀 = 0.327 SD = 0.574 (group)).
It is also important to note that there are significant
differences of both anxiety (𝐹(10) = 14.256; 𝑝 = 0.000 𝑝 <
0.05; 𝜂 = 0.506; Observed Potential = 1.000) and quality of
life (𝐹(13) = 8.995; 𝑝 = 0.000 𝑝 < 0.05; 𝜂 = 0.363; Observed
Potential = 1.000) effect sizes among the instruments adopted.
There is a positive and high correlation between the
number of sessions of relaxation techniques and the effect
sizes of FEV1 (𝑋2 (9) = 90.000; 𝑝 = 0.000 for 𝑝 < 0.05),
indicating that a more constant practice can improve the
FEV1 . In addition, there is a similar connection between the
number of sessions and the anxiety’s effect size (𝑋2 (35) =
280.000; 𝑝 = 0.000 for 𝑝 < 0.05), depression’s effect size
(𝑋2 (40) = 290.000; 𝑝 = 0.000 for 𝑝 < 0.05), and the quality
of life’s effect size (𝑋2 (135) = 1278.000; 𝑝 = 0.000 for 𝑝 <
0.05). Regarding the minutes per session, there are relevant
correlations with the effect size about anxiety (𝑟 = −0.487;
𝑝 = 0.000 for 𝑝 < 0.05), depression (𝑟 = −0.637; 𝑝 = 0.000
for 𝑝 < 0.05), and quality of life (𝑟 = −0.217; 𝑝 = 0.002 for
𝑝 < 0.05). These correlations are negative, which means that
the improvement of one variable such as the relaxation time
is inversely related to the other (e.g., anxiety). There are no
other relevant differences.
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Table 3: Effect sizes of each study included.

Studies
The Effects of Controlled Breathing during Pulmonary Rehabilitation in
Patients with COPD [32]
Can Ventilation-Feedback Training Augment Exercise Tolerance in
Patients with COPD? [37]
VF Alone versus Exercise Alone [37]
Tai Chi Exercise for Patients with Chronic Obstructive Pulmonary
Disease: A Pilot Study [29]
Exercise Maintenance following Pulmonary Rehabilitation Effect of
Distractive Stimuli [34]
Distraction Therapy with Nature Sights and Sounds Reduces Pain
during Flexible Bronchoscopy: A Complementary Approach to Routine
Analgesia [38]
Effects of Progressive Muscle Relaxation Training on Anxiety and
Depression in Patients Enrolled in an Outpatient Pulmonary
Rehabilitation Program [21]
Treatment of Dyspnea in COPD: A Controlled Clinical Trial of Dyspnea
Management Strategies [39]
Efficacy of Pursed-Lips Breathing: A Breathing Pattern Retraining
Strategy for Dyspnea Reduction [40]
EMT versus Control [40]
Diaphragmatic Breathing Training Program Improves Abdominal
Motion during Natural Breathing in Patients with Chronic Obstructive
Pulmonary Disease: A Randomized Controlled Trial [41]
Effects of Singing Classes on Pulmonary Function and Quality of Life of
COPD Patients [42]
Singing Teaching as a Therapy for Chronic Respiratory Disease: A RCT
and Qualitative Evaluation [43]
Yoga Therapy Decreases Dyspnea-Related Distress and Improves
Functional Performance in People with Chronic Obstructive Pulmonary
Disease: A Pilot Study [24]
Effectiveness of a Tai Chi Qigong Program in Promoting Health-Related
Quality of Life and Perceived Social Support in Chronic Obstructive
Pulmonary Disease Clients [44]
Exercise Group versus Control Group [44]
Functional and Psychosocial Effects of Health Qigong in Patients with
COPD: A Randomized Controlled Trial [45]
Singing Classes for Chronic Obstructive Pulmonary Disease: A
Randomized Controlled Trial [46]
Role of Pranayama in Rehabilitation of COPD Patients: A Randomized
Controlled Study [25]
Adjunct Treatment with Yoga in Chronic Severe Airways Obstruction
[47]
Pulmonary Rehabilitation Improves Depression, Anxiety, Dyspnea, and
Health Status in Patients with COPD [48]
Effectiveness of Incorporating Tai Chi in Pulmonary Rehabilitation
Program for Chronic Obstructive Pulmonary Disease Patients in
Primary Health Care (COPD) [49]
Short-Form Sun-Style Tai Chi as an Exercise Training Modality in
People with COPD [50]
Relaxation to Reduce Dyspnea and Anxiety in COPD Patients [51]
One-Session Cognitive Behavioural Therapy for Elderly Patients with
Chronic Obstructive Pulmonary Disease [52]

Effect size: Time 2 (8–12 months)
Effect size BT Effect size BT Effect size BT Effect size BT
%FEV1
anxiety
depression
QoL
0.146

0.397
0.527
0.540

0.725

0.804

1.886

0.512

0.089

−0.133

0.014

0.023

0.114

0.178

0.000
0.281
0.234

0.050

1.137
1.484

0.325

0.392

0.507

0.323

0.134

0.246

0.151

0.019
0.140
1.333
0.110

0.708

1.950

0.099
2.174

0.145
0.790

1.169

−0.140

0.897
0.102

0.632

0.283

0.527

0.084

−0.029

1.154
0.086
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Table 3: Continued.

Studies

Effect size BT
%FEV1

Effects of Psychotherapy in Moderately Severe COPD: A Pilot Study [53]
Comparison of the Effectiveness of Music and Progressive Muscle
Relaxation for Anxiety in COPD: A Randomized Controlled Pilot Study
[54]
Relax and Breathe Deeply: A Quick Relaxation Training for People with
Chronic Obstructive Pulmonary Disease [55] [submitted]

Media (ES between 1(d)_anxiety)

1.414

0.824

0.042
0.678

0.821

0.800
0.600
0.400
0.200
0.000

−0.200
Breathing techniques Yoga
Mixed
(PLB, diaphragmatic)
Intervention
1.200

0.600

0.400

0.200

0.000
6;3

DAS,
PMR Relaxation Yoga
distraction
therapies
therapies
Intervention

0.000
Yoga

Mixed

0.400
0.200
Mixed

0.000
Yoga

0.200

0.600

Tai Chi

0.400

0.800

Relaxation therapies

0.600

6;3

1.000

DAS, distraction therapies

0.800

Mixed

1.200

Breathing techniques (PLB,
diaphragmatic)

Media (ES between 1(d)_QoL)

1.000

PMR Relaxation Tai Chi
DAS,
distraction
therapies
therapies
Intervention

0.800

Biofeedback (RBF, VBT)

Media (ES between 1(d)_FEV1 )

1.414

1.000

1.000

Media (ES between 1(d)_depression)

Effect size: Time 2 (8–12 months)
Effect size BT Effect size BT Effect size BT
anxiety
depression
QoL

Intervention

Figure 4: Effect sizes in relation to the intervention proposed in the studies included. DAS: Distractive Auditory Stimuli; 6;3: relaxation
therapies and breathing techniques; mixed: many relaxation techniques combined together in the same session.

4. Discussion
This meta-analysis evaluated the effects of the relaxation
training on Forced Expiratory Volume in the First Second
(FEV1 ), anxiety, depression, and quality of life of people with
COPD.
The effect sizes concerning all the examined variables are
positive, but they reach only Cohen’s “small effect.” There

is a high heterogeneity between studies, together with a low
stability, probably because the studies included in our analysis
are few and not all of them analyze each of the variables
considered in this research. Moreover, a high level of heterogeneity may be an indication that the overall effectiveness of
the treatment can be attributed to all interventions related to
the application of relaxation techniques, nevertheless having
specific characteristics and different methods of application
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Study or subgroup

van Gestel et al., 2012
Donesky-Cuenco et al., 2009
Volpato et al.
Ng et al., 2014
Tandon, 1978
Katiyar and Bihari, 2006
Yamaguti et al., 2012

Experimental
Mean
SD Total
0.456 0.1429 20
0.512 0.106 14
0.8011 0.216 19
0.6252 0.2765 94
0.0217 0.2117 12
0.52
0.021 23
0.427 0.047 15

Mean
0.4368
0.459
0.6274
0.662
0.0764
0.48
0.427

Control
SD
0.1167
0.202
0.2909
0.2475
0.1663
0.02
0.039

Total (95% CI)
197
Heterogeneity: 𝜒2 = 13.48; df = 6 (p = 0.04); I2 = 56%
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Total
66
15
19
98
12
22
15

Weight

247

100.0%

2.5%
0.9%
0.4%
2.1%
0.5%
81.4%
12.2%

Mean difference
IV, fixed, 95% CI
0.02 [−0.05, 0.09]
0.05 [−0.06, 0.17]
0.17 [0.01, 0.34]
−0.04 [−0.11, 0.04]
−0.05 [−0.21, 0.10]
0.04 [0.03, 0.05]
0.00 [−0.03, 0.03]
0.03 [0.02, 0.04]

Mean difference
IV, fixed, 95% CI
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Test for overall effect: Z = 6.02 (p < 0.00001)

1
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Figure 5: Forest plot of comparison, outcome: FEV1 .
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Figure 6: Funnel plot of comparison, outcome: FEV1 .
Experimental
Mean SD Total
14
13
32
Gift et al., 1992
Donesky-Cuenco et al., 2009
31
8.8
14
Sassi-Dambron et al., 1995
32.2
9.9
46
Volpato et al.
26.05 5.04 19
Diette et al., 2003
44.8
6
41
Bauldoff et al., 2002
12.9 12
33.2
Paz-Díaz et al., 2007
8
5
10
Kunik et al., 2001
12.6
8.7
21
Eiser et al., 1997
11
5
10
Leung et al., 2010–2012
3
3
19
Lolak et al., 2008
3.52
7.95 37
Lord et al., 2010
5.2
2.7
15
Lord et al., 2012
3.6
4.89
13
Singh et al., 2009
30.78
3.2
32
302
Total (95% CI)
Heterogeneity: 𝜒2 = 20.56; df = 13 (p = 0.08); I2 = 37%
Test for overall effect: Z = 1.94 (p = 0.05)
Study or subgroup

Control
Mean SD Total
37
6
13
32.2 9.1
15
33.4 11.2
43
19
31.26 7.43
45.6
6
39
12
38.1 9.8
21
21
14
11.9 7.6
27
7
3
8
6
6
19
4.27 10.76 46
6.1
1.7
13
4.55 2.3
11
31.03 7.7
32
311

Weight
1.2%
1.9%
4.1%
4.8%
11.4%
0.9%
0.6%
3.6%
5.7%
8.7%
4.9%
29.0%
13.9%
9.5%
100.0%

Mean difference
IV, fixed, 95% CI
−5.00 [−13.28, 3.28]
−1.20 [−7.72, 5.32]
−1.20 [−5.60, 3.20]
−5.21 [−9.25, −1.17]
−0.80 [−3.43, 1.83]
−4.90 [−14.07, 4.27]
−13.00 [−24.43, −1.57]
0.70 [−4.00, 5.40]
4.00 [0.27, 7.73]
−3.00 [−6.02, 0.02]
−0.75 [−4.78, 3.28]
−0.90 [−2.55, 0.75]
0.34 [−2.04, 2.72]
−0.25 [−3.14, 2.64]
−0.88 [−1.77, 0.01]

Mean difference
IV, fixed, 95% CI

−50 −25
0
Favours
[experimental]

25
50
Favours
[control]

Figure 7: Forest plot of comparison, outcome: anxiety.

and using various assessment instruments. Precisely for these
reasons, the results should be interpreted with caution. Given
our findings, it can be argued that health-care professionals
should focus on particular variables in the application of
the relaxation trainings and in particular the setting or
therapeutic relationship rather than what patients perceive as
particularly suited to meet their needs, such as information
about their care.

Furthermore, other meta-analyses concerning relaxation
techniques for the management of COPD cannot be found
in literature; consequently, this could constitute an advantage
of this analysis. Effectively, previous systematic studies and
meta-analyses investigated the efficacy of cognitive behavioral or psychotherapeutically based interventions and progressive muscle relaxation, though not distinguishing them
[16]. Others examined the effects of education, exercise,
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Figure 8: Funnel plots of comparison, outcome: anxiety.
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Experimental
Mean SD Total Mean SD Total
14
9.8
Donesky-Cuenco et al., 2009
7
6
15
11.4
Sassi-Dambron et al., 1995
11.2
8.6
46
43
12.8 9.4
Volpato et al.
0
0
0
0
0
0
Bauldoff et al., 2002
12
10.5
9
12
7
14.7
Yeh et al., 2011
5
8.1
5
12.97 5
8
Paz-Díaz et al., 2007
14
6
2
10
11
16
Kunik et al., 2001
27
9.4
6.5
21
7.6
8.8
Eiser et al., 1997
8
11
5
10
3
7
Leung et al., 2010–2012
19
3
3
19
4
4
Lolak et al., 2008
3.136 4.47 37 4.543 7.23 46
Lord et al., 2010
13
4.6
2.5
15
1.7
5.7
Lord et al., 2012
3.8
11
5.93
3.8
13
1.6
213
Total (95% CI)
202
Heterogeneity: 𝜒2 = 24.16; df = 10 (p = 0.007); I2 = 59%
Test for overall effect: Z = 1.25 (p = 0.21)
Study or subgroup

Weight
3.5%
5.6%
1.9%
0.4%
2.3%
5.0%
5.7%
15.7%
12.3%
32.3%
15.3%
100.0%

Mean difference
IV, fixed, 95% CI

Mean difference
IV, fixed, 95% CI
−1.60 [−6.36, 3.16]
−1.60 [−5.35, 2.15]
Not estimable
−4.20 [−10.65, 2.25]
−3.00 [−16.40, 10.40]
−10.00 [−15.89, −4.11]
0.60 [−3.39, 4.59]
4.00 [0.27, 7.73]
−1.00 [−3.25, 1.25]
−1.41 [−3.94, 1.13]
−1.10 [−2.67, 0.47]
2.13 [−0.14, 4.40]
−0.57 [−1.46, 0.32]
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Figure 9: Forest plot of comparison, outcome: depression.
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Figure 10: Funnel plot of comparison, outcome: depression.

and/or psychosocial support [65] in COPD patients, the
effects of psychologically based treatments only on anxiety
and panic in people with COPD [66], or the improvements in
respiratory functions in people with Cystic Fibrosis (CF) generated by meditative movements [67]. Finally, other authors
investigated the effectiveness of nonpharmacological and
noninvasive interventions to relieve breathlessness in participants with advanced stages of cancer, Chronic Obstructive

Pulmonary Disease (COPD), interstitial lung disease, chronic
heart failure, or motor neuron disease [68]. Therefore, despite
the fact that our meta-analysis did not produce striking
results, the study could be a valuable tool for increasing the
knowledge about a more effective application of relaxation
techniques in COPD patients. However, it is also important to
note that, in addition to the limits discussed in this paragraph,
we should pay attention to the fact that some criteria were
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Experimental
Mean SD Total
15
30.5 5.8
Bonilha et al., 2009
van Gestel et al., 2012
0.64 0.85
20
Chan et al., 2010
41.2 15.8
70
Chan et al., 2010-2nd group
40.4 16.1
69
Ng et al., 2011
54 5.17
23
Collins et al., 2007-2008-2nd group
0 13.53 22
Donesky-Cuenco et al., 2009
35.4 9.7
14
Sassi-Dambron et al., 1995
0.66 0.07
46
Collins et al., 2007-2008
22
45.8 4.48
Bauldoff et al., 2002
3
15.8
12
Yeh et al., 2011
5.4 3.66
5
Paz-Díaz et al., 2007
45
12
10
Ng et al., 2014
28.6 18.33 94
Nield et al., 2007-2nd group
13
27
16
Nield et al., 2007
16
14
33
Kunik et al., 2001
21
34.8 29.2
Eiser et al., 1997
10
49
19
Leung et al., 2010–2012
19
6.5
5
Katiyar and Bihari, 2006
23
40
2.3
Lord et al., 2010
47.7 10.6
15
Lord et al., 2012
13
49.4 19
Yamaguti et al., 2012
43.9 17.52 15
565
Total (95% CI)
Heterogeneity: 𝜒2 = 109.38; df = 21 (p < 0.00001); I2 = 81%
Test for overall effect: Z = 0.11 (p = 0.91)
Study or subgroup
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Mean SD
40.7
7.8
0.48 0.85
41.5 15.4
43.4 14.8
47.24 4.99
12.82
0
8.8
36.8
0.1
0.66
4.22
3
40.5 13.9
2.91
5.3
16
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26.72 18.39
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31
23
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35.6 25.5
17
63
4.6
1
2.3
53
5.6
44.9
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54.8 21.8
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0.0%
0.5%
20
0.0%
67
0.0%
67
0.0%
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0.0%
20
0.0%
15
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43
0.0%
20
0.0%
12
0.0%
5
0.0%
14
0.0%
98
0.0%
13
0.0%
13
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27
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8
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Figure 11: Forest plot of comparison, outcome: quality of life.
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very specific, which can be a strength but also a limitation
with respect to the inclusion of other studies.
Using a between-group analysis it was possible to outline
the effects produced by these techniques and the effects
derived from the time of the application of usual care. One
of the most obvious benefits is that the meta-analysis allows
us to integrate the research literature relating to the same
subject, beyond the limitations of each study considered
separately. In addition, using data from different studies,
it is possible to increase the accuracy compared to the
estimate of the treatment efficacy and detect effects previously
latent, since the individual studies are characterized by
a low statistical weight. Moreover, the presence of metaanalytical studies in literature should encourage researchers
to proceed in a methodologically rigorous way in conducting
their experiments, just to greatly increase the odds of their
inclusion [69]. However, in this as well as in other metaanalyses, there appears to be a limit, that is, the need for the

pooled studies to have very similar characteristics in order
to avoid false conclusions from certain intervening variables
which have not been attended to or considered influential
[70]. Furthermore, it is important to note that it is difficult to
derive conclusions from effect sizes on real patients; indeed,
the data examined in meta-analysis tend to focus on a subject
“average,” which is eligible for part of a research design. It
is also important to note that many of the studies did not
consider all the variables examined as moderators of the
effect, an aspect that can significantly reduce the stability
of the same meta-analysis and therefore the ability to draw
firm conclusions. Moreover, there is also a limit to the
generalizability of results, because we restricted the search
to some computerized databases and we adopted only RCT
studies as inclusion criteria. Moreover, the number of studies
considered is small, due to the fact that in the literature many
studies did not report essential information for computing
the effect sizes. Consequently, it is necessary to be cautious
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when interpreting the results, especially when there is low
heterogeneity detected between studies, as well as the low
stability of the analysis.
These considerations may therefore have important
implications for future studies; from a theoretical point of
view, they might be useful for identifying new factors that
moderate the effects of various dimensions, while, from
a methodological point of view, they would be useful for
adopting measurements, that is, more stringent and sampling
techniques, but most importantly control strategies. Moreover, despite the fact that this meta-analysis has failed to
reveal significant effects of the implementation of relaxation
techniques for COPD management, it can be a starting point
for understanding how to increase the quality of the proposed
interventions, pointing out that many studies that have been
considered separately demonstrated some sort of efficacy.

5. Conclusions
Even if this meta-analysis is not able to reveal the effectiveness
of relaxation techniques, it is important to remind ourselves
that there are previous studies which have demonstrated that
these trainings sessions could decrease anxiety and psychological distress and produce benefits for some physiological
parameters such as oxygen saturation and heart rate not
exclusively in people with COPD [71–73]. Future studies are
necessary, while taking methodological precautions such as
paying attention to the sampling techniques, measurements,
confounding variables, and control strategies.
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